QPS Holdings, LLC divests its Neuropharmacology Business Unit

[ad_1] This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia…

Scantox acquires QPS Austria’s Neuropharmacology Division | BioSpace

[ad_1] EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ — Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH (“QPS Neuro” or…

Scantox acquires QPS Austria’s Neuropharmacology Division

[ad_1] EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ — Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH (“QPS Neuro” or “the…